BETA

Awaiting committee decision



2017/2710(DEA) Principles of and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections
RoleCommitteeRapporteurShadows
Lead ENVI
Lead committee dossier: ENVI/8/10003

Activites

  • 2017/05/31 Committee referral announced in Parliament, 1st reading/single reading
  • 2017/05/23 Initial period for examining delegated act 2 month(s)
  • 2017/05/23 Non-legislative basic document published

Documents

History

(these mark the time of scraping, not the official date of the change)

activities/3
date
2017-07-17T00:00:00
body
EP/CSL
type
Delegated act not objected by Council
activities
  • date: 2017-05-23T00:00:00 body: EP/CSL type: Initial period for examining delegated act 2 month(s)
  • date: 2017-05-23T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/actes_delegues/2017/03368/COM_ADL(2017)03368_EN.pdf type: Non-legislative basic document published title: C(2017)03368 body: EC type: Non-legislative basic document published commission:
  • date: 2017-05-31T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
committees
  • body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
links
other
    procedure
    dossier_of_the_committee
    ENVI/8/10003
    reference
    2017/2710(DEA)
    title
    Principles of and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections
    stage_reached
    Awaiting committee decision
    summary
    Supplementing
    subtype
    Examination of delegated act
    type
    DEA - Delegated acts procedure
    subject
    4.20.04 Pharmaceutical products and industry